NEKTAR THERAPEUTIC revenue breakdown overview

NEKTAR THERAPEUTIC revenue for the last year amounted to 89.39 M CHF, the most of which — 89.39 M CHF — came from its highest performing source at the moment, Novel Drug Candidates, the year earlier bringing 75.88 M CHF. The greatest contribution to the revenue figure was made by Rest of World — last year it brought NEKTAR THERAPEUTIC 88.14 M CHF, and the year before that — 66.21 M CHF.